Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Gynecologic 1

Conditions

Nasopharyngeal Carcinoma 14Triple Negative Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Esophageal Squamous Cell Carcinoma 9Breast Neoplasms 8Colorectal Neoplasms 7Carcinoma, Renal Cell 7Small Cell Lung Carcinoma 6Neoplasms 6Advanced Solid Tumor 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Recurrence 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Solid Tumor 3Neoplasm Metastasis 3Liver Neoplasms 3Carcinoma, Transitional Cell 3Turcot syndrome 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2NSCLC 2Muscle Invasive Bladder Cancer (MIBC) 2Carcinoma, Squamous Cell 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2

Interventions

Cyclophosphamide 51fludarabine 37Dexamethasone 35venetoclax 30pembrolizumab 25Rituximab 20pomalidomide 18Lenalidomide 17Gemcitabine 17fludarabine phosphate 15Etoposide 14Cytarabine 13daratumumab 12carfilzomib 11Temozolomide 11Injections 10Calcium Dobesilate 10glofitamab 9Nivolumab 9Cisplatin 9Bortezomib 9Azacitidine 9selinexor 8Vincristine 8Immunotherapy, Adoptive 8obinutuzumab 7cemiplimab 7Drug Therapy 7Carboplatin 7zanubrutinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recurrence × toripalimab × 1 year × Clear all
NCT07423078 2026-04-13

WOLF

University of Pittsburgh

Phase 2 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT07363330 2026-01-26

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Zhongnan Hospital

Phase 2 Not yet recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT07258979 2025-12-02

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

MediLink Therapeutics (Suzhou) Co., Ltd.

Phase 1/2 Recruiting
202 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT07097948 2025-08-01

Adjuvant

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
40 enrolled
Thoracic

Recurrence, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡